Virological outcomes
No significant difference in viral clearance was observed between the CPT-FPV and sotrovimab groups. On day 5, the viral clearance rates were 7% for CPT-FPV and 13.4% for sotrovimab (Analysis of radiologic and virological outcomes in COVID-19 patients treated with sotrovimab versus combined COVID-19 convalescent plasma therapy with favipiravirOutcomes are presented in terms of frequency and percentage for each parameter. Proportional differences between the two treatment modalities are highlighted along with their corresponding 95% confidence intervals.

Calculations were done using the Pearson chi-squared test or.Fisher’s exact test where appropriate.